4.6 Article

A novel circular RNA circFN1 enhances cisplatin resistance in gastric cancer via sponging miR-182-5p

Journal

JOURNAL OF CELLULAR BIOCHEMISTRY
Volume 122, Issue 9, Pages 1009-1020

Publisher

WILEY
DOI: 10.1002/jcb.29641

Keywords

circFN1; circular RNA; cisplatin resistance; gastric cancer; miR-182-5p

Funding

  1. Health Science and Technology Project Of Lianyungang [201914]
  2. Climbing Cultivation Plan for the Science and Technology Innovation Team of Yanjishan Hospital of Wannan Medical College [PF2019009]
  3. University Natural Science Research Project of Anhui Province [KJ2017A272, KJ2018A0247, KJ2019A0412, KJ2019A0429]
  4. Wannan Medical College Cultivation Fund of the Key Scientific Project [WK2017ZF10]
  5. Science and Technology Development Fund of Kangda College of Nanjing Medical University [KD2019KYJJZD009]
  6. National Natural Science Foundation of China [81902515]

Ask authors/readers for more resources

This study examines the mechanism of CDDP resistance in GC, identifying circFN1 as a potential therapeutic target for patients. It was found that circFN1 is upregulated in CDDP-resistant GC cells and tissues, correlates with aggressive biological behavior, and promotes cell survival by inhibiting apoptosis, suggesting its role in CDDP resistance and as a potential therapeutic target.
Cisplatin (CDDP) is commonly used for gastric cancer (GC) chemotherapy. However, after several CDDP-based treatment cycles, patients always acquire chemotherapy resistance, which limits the overall clinical efficacy of the treatment. Clarification of the mechanisms responsible for CDDP resistance is required to improve therapeutic outcomes for patients. Circular RNAs (circRNAs) are noncoding RNAs involved in the pathogenesis of cancer, although their role in the mechanism underlying CDDP resistance in GC remains unknown. In the present study, we explored the underlying roles of circRNAs in the modulation of CDDP resistance in CDDP-sensitive and CDDP-resistant human GC cells. Using RNA sequencing and quantitative reverse transcription polymerase chain reaction, expression of circFN1 (originating from exons 10, 11, and 12 of the FN1 gene hsa_circ_0058147) was higher in CDDP-resistant GC cells and tissues. CircFN1 upregulation in GC patients treated by CDDP was significantly correlated with aggressive biological behavior. CircFN1 promoted viability and inhibited apoptosis of GC cells exposed to CDDP in vivo and in vitro. Furthermore, circFN1 suppressed GC cell apoptosis by sponging miR-182-5p. These findings demonstrate the involvement of circFN1 in CDDP resistance of GC and implicate circFN1 as a therapeutic target for GC patients treated with CDDP. It provides novel evidence of the function of circRNAs as microRNA sponges and highlight a potential therapeutic target for extinguishing CDDP resistance in patients with GC.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available